DELYVANT Trademark

Trademark Overview


On Friday, June 28, 2013, a trademark application was filed for DELYVANT with the United States Patent and Trademark Office. The USPTO has given the DELYVANT trademark a serial number of 85972919. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 1, 2014. This trademark is owned by Glaxo Group Limited. The DELYVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
delyvant

General Information


Serial Number85972919
Word MarkDELYVANT
Filing DateFriday, June 28, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "DELYVANT" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 11, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Tuesday, September 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 29, 2013ASSIGNED TO LIE
Friday, October 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 11, 2013EXAMINER'S AMENDMENT ENTERED
Friday, October 11, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 11, 2013EXAMINERS AMENDMENT E-MAILED
Friday, October 11, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 9, 2013ASSIGNED TO EXAMINER
Thursday, July 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 2, 2013NEW APPLICATION ENTERED IN TRAM